Related Experiment Video
Updated: Jul 6, 2025
11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
19.3K
Dynamics of receptor activation by agonists
1Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, New York.
Biophysical Journal
|January 5, 2024
Summary
Agonists activate muscle nicotinic acetylcholine receptors by binding to neurotransmitter sites. This binding energy measurement reveals how receptor dynamics link to channel gating.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Nicotinic acetylcholine receptors (nAChRs) are crucial ligand-gated ion channels.
- Understanding how agonists activate these receptors is key to their function.
Purpose of the Study:
- To summarize how agonist binding energy measurements elucidate receptor dynamics.
- To explore the link between neurotransmitter binding and channel gating.
Main Methods:
- Utilizing adult-type skeletal muscle nicotinic acetylcholine receptors as a model system.
- Measuring agonist binding energy to probe receptor dynamics.
Main Results:
- Agonist binding energy measurements reveal dynamics of neurotransmitter sites.
- A fundamental link between binding energy and receptor gating is established.
Conclusions:
- Agonist binding to orthosteric sites influences the allosteric gating site.
- This provides insight into the mechanism of nAChR activation.
Related Concept Videos
01:29The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
01:25Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
01:29Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
01:30Spare Receptors
3.6K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
3.6K
01:03Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
01:22Activation and Inactivation of G Proteins
7.2K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.2K